MedTrace Logo

Testing Integrative Smoking Cessation for HIV Patients

NCT05030766 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2025-06-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.

Conditions

  • Smoking
  • Smoking Cessation
  • HIV Infections

Interventions

DRUG

Nicotine Replacement Therapy

6 weeks of Nicotine replacement patches

BEHAVIORAL

Mindfulness Training Smoking Cessation Intervention

Mindfulness Training Smoking Cessation Intervention administered online via Zoom. Each session lasts 60-90 minutes, twice weekly for 4 weeks for a total of 8 sessions.

BEHAVIORAL

Contingency Management Smoking Cessation Intervention

Contingency Management Smoking Cessation Intervention includes one orientation session lasting about 60-90 minutes administered via Zoom. Participants will then be required to contact the research associate about their quitting progress three times a week for 4 weeks also by zoom.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Taghrid A. Asfar, MD, MSPH · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-04
Primary Completion
2024-05-23
Completion
2024-05-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05030766 on ClinicalTrials.gov